A critical appraisal and clinical application of Manzardo C, Esteve A, Ortega N, et al. Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS Cohort. Clin. Microbiol. Infect. 2013 July;19(7):646-653. doi: 10.1111/j.1469-0691.2012.03991.x
Winkler ML. Early HAART should be used for treatment-naive HIV patients with Pneumocystis pneumonia. Clinical Research in Practice: The Journal of Team Hippocrates. 2016 Aug 26;2(2):eP1105.